MYC and neoplasm: Moreover, tumour cells can take up acetate and convert it to acetyl‐CoA through ACSS2, resulting in elevated c‐Myc acetylation, which in turn reprograms tumour metabolism and enhances PD‐L1 expression and immune evasion.56